Lower carbohydrate diets for adults with type 2 diabetes
Mamta Singh1, Estella S Hung1, Adrienne Cullum1
1SACN Secretariat, Department of Health and Social Care, Office for Health Improvement & Disparities, London, United Kingdom.
The British Journal of Nutrition
|November 1, 2021
Summary
The Scientific Advisory Committee on Nutrition (SACN) assessed lower carbohydrate diets for adults with type 2 diabetes (T2D). The review compared lower versus higher carbohydrate intakes, noting the lack of a universal
Area of Science:
- Nutritional Science
- Public Health Nutrition
- Dietary Risk Assessment
Background:
- The Scientific Advisory Committee on Nutrition (SACN) evaluated lower carbohydrate diets for adults with type 2 diabetes (T2D).
- A joint working group (WG) was formed in 2017, comprising SACN members and representatives from key UK health organizations, to address this clinical nutrition issue.
- SACN typically focuses on healthy populations, necessitating a specialized group for clinical condition-related assessments.
Purpose of the Study:
- To review evidence comparing lower carbohydrate diets against current UK government advice for T2D management.
- To assess the risks and benefits of varying carbohydrate intakes in adults with T2D.
- To inform potential dietary recommendations for T2D based on scientific evidence.
Main Methods:
- A comprehensive review of scientific evidence on lower carbohydrate diets versus higher carbohydrate diets for T2D.
- Comparison of dietary patterns based on available evidence, acknowledging the absence of a standardized definition for 'low-carbohydrate' diets.
- Expert consensus and evidence synthesis by a joint working group from multiple health bodies.
Main Results:
- The report focused on comparisons between lower and higher carbohydrate diets due to the lack of a universally agreed definition for 'low-carbohydrate' diets.
- Evidence was evaluated to understand the implications of different carbohydrate intakes for adults with T2D.
- The assessment considered risks and benefits pertinent to public health and clinical management.
Conclusions:
- The SACN report provides a risk assessment on lower carbohydrate diets for adults with type 2 diabetes.
- The findings highlight the need for clarity on definitions and evidence-based guidance for dietary interventions in T2D.
- The joint working group's approach facilitated a focused evaluation of this specific dietary strategy for a clinical population.
Keywords:
AdultsLower carbohydrate dietsRandomised controlled trialsScientific Advisory Committee on NutritionType 2 diabetesMore Related Videos
Related Concept Videos
Carbohydrate Metabolism
12.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.6K
Diabetes Mellitus: Type 2 and Gestational
3.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications
1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Overview of Carbohydrate Metabolism
2.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.6K
Diabetes: Management and Pharmacotherapy
563
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
563


